Gooderham M, Torres T, Imafuku S, Rademaker M, et al. Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up). Br J Dermatol 2025 Jun 23:ljaf236. doi: 10.1093.
PMID: 40581082